Product
TT-00434
1 clinical trial
1 indication
Indication
CancerClinical trial
A Phase I Study of the Safety, Tolerability, Pharmacokinetics Profile, and Preliminary Efficacy of TT-00434 in Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2023-10-18